Correction: Arthritis Res Ther 24, 251 (2022)
https://doi.org/10.1186/s13075-022-02943-2
Following publication of the original article [1], an error was identified in the Funding section.
The updated funding is given below and the changes have been highlighted in bold.
Funding
A.M.B. was supported by Tobe and Stephen E. Malawista, MD, Endowment in Academic Rheumatology, Rheumatology Research Foundation and by NIH/NHLBI HL155955-01A1. F.E. is supported by NIH 5T32HL007224-45, M.T. is funded by NIAMS P50 AR060780, F.S. is funded by NIH/NHLBI R01HL145985, and J.K.L is funded by NIH/NHLBI1F32HL156614-01.
The original article [1] has been updated.
Reference
- 1.El-Adili F, Lui JK, Najem M, et al. Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications. Arthritis Res Ther. 2022;24:251. doi: 10.1186/s13075-022-02943-2. [DOI] [PMC free article] [PubMed] [Google Scholar]